Languages
Page last updated at 12:36 GMT, Monday, 12 November 2007

Questions over drugs for ADHD

Panorama logo

Treating children who have Attention Deficit Hyperactivity Disorder (ADHD) with drugs has no advantage over other treatments in the long term, research has shown.

A study obtained by the BBC's Panorama programme says drugs such as Ritalin and Concerta work no better than therapy after three years of treatment.

The findings by an influential US study also suggested long-term use of the drugs could stunt children's growth.

The Multimodal Treatment Study of Children with ADHD has been monitoring the treatment of 600 children across the US since the 1990s.

In 1999, the American study concluded that after 14 months, medication worked better than behavioural therapy for ADHD.

DH STATEMENT

The study now concludes that this advantage is lost after 36 months.

Most of the estimated 500,000 children in Britain with ADHD receive no treatment at all.

But of those that do, most - about 55,000 last year - are prescribed stimulants like Ritalin and Concerta.

The cost of these drugs to the NHS is about £28m.

The National Institute for Clinical Excellence is currently revising the treatment guidelines for ADHD.

Panorama: What Next for Craig? BBC One 8.30pm, Monday, 12 November 2007


Correction February 19 2010: Following a ruling by the BBC Trust, this report has been amended and some material removed. Details of the Trust's finding can be found here. The Panorama programme was also the subject of a ruling by the BBC's Editorial Complaints Unit, which can be found here.



Print Sponsor


SEE ALSO
No such thing as naughty anymore?
14 Mar 07 |  Health
Use of hyperactivity drugs soars
07 Mar 07 |  Health
Panorama: Kids on Pills
01 Oct 00 |  Archive

RELATED BBC LINKS

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites


FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

PRODUCTS & SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific